April 30, 2021
April 30, 2021
CDMO Business Driven by Custom Solutions from Bench to Market for the Development and Manufacture of Difficult to Formulate Drugs and Highly Potent Compounds BOONTON, […]
March 16, 2021
March 16, 2021
BOONTON, N.J., March 16, 2021 — Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of […]
January 12, 2021
January 12, 2021
Boonton, NJ – January 12, 2021 – Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned […]
January 7, 2021
January 7, 2021
Enteris poised to capitalize on multiple value building opportunities involving Peptelligence® and ProPerma™ platforms Rajiv Khosla, Ph.D., named Chief Executive Officer Gary A. Shangold, M.D., […]
December 24, 2020
December 24, 2020
Second milestone payment related to the development of Oral KORSUVA™ follows initial $2.5 million milestone payment received in October Dallas, TX, December 24, 2020 – SWK […]
December 17, 2020
December 17, 2020
Boonton, NJ – December 17, 2020 – Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned […]
October 27, 2020
October 27, 2020
Dallas, TX – October 27, 2020 – SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, […]
KNOWLEDGE CENTER
Expand your knowledge. The Enteris BioPharma Knowledge Center is a library of educational tools.
LEARN MOREKNOWLEDGE CENTER
Expand your knowledge. The Enteris BioPharma Knowledge Center is a library of educational tools.
LEARN MORE
